









Markets
/
Stocks
/
nasdaq-rgen
/

Repligen Corp

RGEN

View Detailed Chart

120.500USD

-0.830-0.68%

Market hours （ET）Quotes delayed by 15 min

6.77BMarket Cap

LossP/E TTM



Repligen Corp

120.500

-0.830-0.68%

Overview Company Financials

Financials

Intraday

30m

Today

-0.68%

5 Days

-3.16%

1 Month

-5.51%

6 Months

-23.03%

Year to Date

-16.28%

1 Year

-4.30%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 20 analysts

BUY

Current Rating

181.000

Target Price

39.03%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Repligen Corp

RGEN

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Dexcom Inc

DXCM

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(9)

Neutral(2)

Buy(1)

Indicators

Sell(3)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.648

Buy

RSI(14)

43.074

Neutral

STOCH(KDJ)(9,3,3)

36.781

Sell

ATR(14)

4.803

Low Volatility

CCI(14)

-78.025

Neutral

Williams %R

96.970

Oversold

TRIX(12,20)

0.091

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

128.780

Sell

MA10

127.358

Sell

MA20

124.992

Sell

MA50

126.400

Sell

MA100

133.680

Sell

MA200

140.882

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

Ticker SymbolRGEN

CompanyRepligen Corp

CEOMr. Olivier Loeillot

Websitehttps://www.repligen.com/